anti-Fatty Acid Binding Protein 5 (Psoriasis-Associated) (FABP5) Antibodies

Human Fatty Acid Binding Protein 5 (Psoriasis-Associated) (FABP5) interaction partners

1. Compared to control group, breast cancer patients show higher FABP4 (show FABP4 Antibodies) and FABP5 blood levels. Our data suggest that, particularly, circulating FABP4 (show FABP4 Antibodies) levels could be considered a new independent breast cancer biomarker. Our work translates basic science data to clinic linking the relationship between adipose tissue and lipid metabolism to breast cancer.

2. the critical role of FABP5 in activating the TGF-beta (show TGFB1 Antibodies) signaling pathway during radiation-induced human skin fibrosis

3. Study identified FABP5 to be involved in the progressive intestinal injury associated with the development of Crohn's Disease complications via their effects on intestinal innate immunity.

4. Findings show that FABP5 expression is up-regulated in hepatocellular carcinoma (HCC (show FAM126A Antibodies)), and provide evidence that that it could play a crucial role of tumor progression, invasion and metastasis in HCC (show FAM126A Antibodies) through EMT (show ITK Antibodies) induction.

5. Circulating levels of AFABP and EFABP are not decreased in Lipodystrophy despite adipose tissue loss in contrast to other adipokines including leptin and adiponectin.

6. A high expression ratio between FABP5 and CRABPII (show CRABP2 Antibodies) may be related to CP tumor recurrence and ATRA could be a potential therapeutic agent for CP chemotherapy.

7. Data suggest that antinociceptive agent SBFI-26 binds at a portal site as well as at the canonical site in the substrate pocket of FABP5 and FABP7 (show FABP7 Antibodies); only the S form of SBFI-26 binds to both FABP5 and FABP7 (show FABP7 Antibodies) in their co-crystal structures; SBFI-26 induces conformational changes in FABP5 and FABP7 (show FABP7 Antibodies).

8. secreted FABP4 and FABP5 from adipocytes as adipokines differentially affect transcriptional and metabolic regulation in ADSC near adipocytes

9. FABP5 plays an important role in the carcinogenesis and metastasis of cervical cancer, and FABP5 may be a novel predictor for prognostic assessment of cervical cancer patients.

10. FABP5 promoted VEGF expression and angiogenesis through PPARgamma which was activated by fatty acids transported by FABP5.

Mouse (Murine) Fatty Acid Binding Protein 5 (Psoriasis-Associated) (FABP5) interaction partners

1. Fabp4 (show FABP4 Antibodies)/5 confers protection against metabolic diseases but does not extend lifespan.

2. Lack of PPARbeta (show PPARD Antibodies)/delta-expression, TUNEL reaction, RA receptor (RAR)beta (show RARB Antibodies), and cellular retinoic acid-binding protein (CRABP (show CRABP2 Antibodies))-II (show CRABP2 Antibodies) were induced in E-FABP-positive septoclasts under RA excess, suggesting the growth arrest/cell-death of septoclasts, whereas cartilage-derived retinoic acid-sensitive protein (CD-RAP (show MIA Antibodies)) inducing the cell growth arrest or morphological changes was induced in septoclasts under VA deficiency.

3. A 42.1 +/- 12.6% decrease in the BBB transport of (14) C-DHA in 8-month-old AD transgenic mice relative to wild-type mice was associated with a 34.5 +/- 6.7% reduction in FABP5 expression in isolated brain capillaries. Short-term spatial and recognition memory deficits were seen in AD mice on a 6-month n-3 fatty acid-depleted diet, but not those on control diet.

4. Using a yeast two-hybrid screen, immunoprecipitation, microscale thermophoresis analysis and cellular fractionation, we discovered that Fabp5 interacts with the calnexin (show CANX Antibodies) cytoplasmic C-tail domain at the endoplasmic reticulum. These observations identify Fabp5 as a previously unrecognized calnexin (show CANX Antibodies) binding partner.

5. Following infection with Listeria monocytogenes, we observed similar clonal expansion, contraction and formation of memory CD8 T cells in WT and E-FABP-/- mice. Analysis of Listeria-specific CD4 T cells revealed no defect in the expansion, contraction, and formation of memory CD4 T cells in E-FABP-/- mice. Our data demonstrate that E-FABP is dispensable for antigen-specific T cell response following bacterial infection.

6. Genetic deletion of fatty acid-binding protein 5 (FABP5) in mice reduces uptake of exogenous docosahexaenoic acid (DHA) into brain endothelial cells and brain capillaries and reduces brain parenchymal levels of endogenous DHA. Therefore, FABP5 in the brain endothelial cell is a crucial contributor to the brain levels of DHA. Critically, lowered brain DHA levels in FABP5(-/-) mice occurred in tandem with cognitive deficits

7. the balance between FABP4 and FABP5 in endothelial cells may be important in regulation of angiogenic versus quiescent phenotypes in blood vessels.

8. Mice lacking FABP5 and FABP7 (show FABP7 Antibodies), which exhibit highest affinities for endocannabinoids, possessed elevated levels of the endocannabinoid anandamide and the related N-acylethanolamines palmitoylethanolamide and oleoylethanolamide.

9. These studies show, for the first time, a correlation between FABP5 and EGFR (show EGFR Antibodies) in enhancing TNBC metastasis through a novel mechanism

10. loss of FABP5 promotes a more anti-inflammatory response.

Pig (Porcine) Fatty Acid Binding Protein 5 (Psoriasis-Associated) (FABP5) interaction partners

1. FABP4 gene expression level in adipose tissue was higher than in muscle. In contrast, FABP5 was expressed at low levels in adipocytes and muscle tissues. Low and moderate correlations between FABP4 and FABP5 gene expression were observed in muscle and in backfat, respectively.

2. QTL and haplotype analysis revealed that both FABP4 (show FABP4 Antibodies) and FABP5 (clustered in mammals) are major candidate genes for the FAT1 (show FAT1 Antibodies) QTL; the most likely position for the FAT1 (show FAT1 Antibodies) QTL is between these two genes.